BrainsWay Ltd. (BWAY) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
BWAY Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, BrainsWay Ltd. (BWAY) trades at a price-to-earnings ratio of 45.6x, with a stock price of $16.41 and trailing twelve-month earnings per share of $0.36.
The current P/E is 27% below its 5-year average of 62.0x. Over the past five years, BWAY's P/E has ranged from a low of 38.0x to a high of 149.8x, placing the current valuation at the 57th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, BWAY trades at a 106% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, BWAY commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BWAY DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BWAY P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $215M | 30.2 | 2.35 | +48% | |
| $150B | 11.3 | 0.38Best | +134% | |
| $99B | 21.5 | - | +31% | |
| $83B | 28.9 | - | +55% | |
| $17B | 30.5 | - | -25% | |
| $2B | 6.8Lowest | 0.66 | +817%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
BWAY Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $9.51 | $0.25 | 38.0x | -39% |
| FY2025 Q3 | $7.54 | $0.15 | 49.9x | -20% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $6.58 | $0.15 | 43.5x | -30% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $4.74 | $0.12 | 39.1x | -37% |
| FY2024 Q4 | $4.72 | $0.10 | 45.2x | -27% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $4.62 | $0.07 | 68.8x | +11% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $3.04 | $0.02 | 149.8x | +141% |
Average P/E for displayed period: 62.0x
See BWAY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BWAY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BWAY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBWAY — Frequently Asked Questions
Quick answers to the most common questions about buying BWAY stock.
Is BWAY stock overvalued or undervalued?
BWAY trades at 45.6x P/E, below its 5-year average of 62.0x. At the 57th percentile of historical range, the stock is priced at a discount to its own history.
How does BWAY's valuation compare to peers?
BrainsWay Ltd. P/E of 45.6x compares to sector median of 22.1x. The premium reflects expected growth above peers.
What is BWAY's PEG ratio?
BWAY PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.